Cosmo Pharmaceuticals NV (XSWX:COPN)
CHF 71.6 0.6 (0.85%) Market Cap: 1.15 Bil Enterprise Value: 1.10 Bil PE Ratio: 0 PB Ratio: 2.86 GF Score: 68/100

Full Year 2020 Cosmo Pharmaceuticals NV Earnings Call Transcript

Mar 26, 2021 / 01:00PM GMT
Release Date Price: CHF86.8 (+0.58%)
Operator

Ladies and gentlemen, welcome to the Cosmo Pharmaceuticals 2020 Results and 2021 Outlook Conference Call. I am Alice, the Chorus Call operator.

(Operator Instructions)

And the conference is being recorded.

(Operator Instructions)

The conference must not be recorded for publication or broadcast. At this time, it's my pleasure to and over to the management team of Cosmo Pharmaceuticals. Please go ahead.

Alessandro E. Della ChÃ
Cosmo Pharmaceuticals N.V. - CEO & Executive Director

Good afternoon, everyone. This is Alessandro Della Chà , the CEO of Cosmo. And on the call with me also Niall Donnelly, the CFO. Thanks for joining. 2020 has been a very interesting year for Cosmo. Notwithstanding the pandemic, we have had major advancements on basically all fronts. We've seen a streak of approval. We've seen the return to operating profit, and we have seen the return to positive cash inflow from operating activities.

So our outlook now looks very different from 2019, and we're very happy that we've been able to reach

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot